Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.29 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 4:30 PM 12/12/14 All times are local (Market data is delayed by at least 15 minutes).

reva medical inc - cdi (RVALL) Snapshot

Open
--
Previous Close
$0.29
Day High
--
Day Low
--
52 Week High
11/24/14 - $0.30
52 Week Low
09/15/14 - $0.13
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
335.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for REVA MEDICAL INC - CDI (RVALL)

Related News

No related news articles were found.

reva medical inc - cdi (RVALL) Related Businessweek News

No Related Businessweek News Found

reva medical inc - cdi (RVALL) Details

REVA Medical, Inc., a development stage medical device company, focuses on the commercialization of minimally invasive medical devices for the treatment of coronary artery disease in the human heart. It is developing and testing a bioresorbable stent to treat vascular disease in humans under the Fantom scaffolds name. The company was formerly known as MD3, Inc. and changed its name to REVA Medical, Inc. in March 2002. REVA Medical, Inc. was founded in 1998 and is headquartered in San Diego, California.

46 Employees
Last Reported Date: 03/30/15
Founded in 1998

reva medical inc - cdi (RVALL) Top Compensated Officers

Co-founder, Chairman and Chief Executive Offi...
Total Annual Compensation: $359.7K
President and Chief Operating Officer
Total Annual Compensation: $340.8K
Chief Financial Officer and Company Secretary
Total Annual Compensation: $275.2K
Senior Vice President of Clinical and Regulat...
Total Annual Compensation: $260.9K
Senior Vice President of Product Development
Total Annual Compensation: $254.0K
Compensation as of Fiscal Year 2013.

reva medical inc - cdi (RVALL) Key Developments

REVA Medical, Inc. Expands FANTOM II Clinical Trial to Europe

REVA Medical, Inc. announced that the FANTOM II clinical trial, which began enrolling patients with the Fantom sirolimus-eluting bioresorbable scaffold in March in Brazil, is now enrolling patients in Europe. The Fantom scaffold, made from REVA's advanced proprietary polymer, is designed to allow the restoration of blood flow in patients being treated for coronary artery disease, then resorb from the body over time.

REVA Medical, Inc. Reports Audited Consolidated Earnings Results for the Full Year Ended December 31, 2014

REVA Medical, Inc. reported audited consolidated earnings results for the full year ended December 31, 2014. For the year, the company reported loss from operations of $21,963,000 compared to loss from operations of $27,943,000 for the same period a year ago. Net loss and comprehensive loss was $51,037,000 or $1.53 per basic and diluted share compared to $27,922,000 or $0.84 per basic and diluted share last year. Net cash used for operating activities was $17,930,000 compared to $21,943,000 last year. Purchases of property and equipment were $541,000 compared to $1,466,000 last year.

REVA Medical, Inc. Appoints Scott Huennekens as Non-Executive Director

REVA Medical, Inc. announced that Scott Huennekens, a recognized business executive in the medical device industry, has been appointed to its Board of Directors as a non-executive director. Mr. Huennekens currently serves on the boards of EndoChoice, Sonendo, Scripps Translational Science Institute, and the Medical Device Manufacturers Association (MDMA).

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RVALL:US $0.29 USD 0.00

RVALL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RVALL.
View Industry Companies
 

Industry Analysis

RVALL

Industry Average

Valuation RVALL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REVA MEDICAL INC - CDI, please visit www.revamedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.